Dabigatran contraindications: Difference between revisions

Latest revision as of 02:33, 22 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Dabigatran#Contraindications]]
-{{Dabigatran}}
-{{CMG}}; {{AE}} {{SS}}
-==Contraindications==
-PRADAXA is contraindicated in patients with:
-*Active pathological bleeding [see Warnings and Precautions (5.2) and Adverse Reactions (6.1)].
-*History of a serious hypersensitivity reaction to PRADAXA (e.g., anaphylactic reaction or anaphylactic shock) [see Adverse Reactions (6.1)].
-*Mechanical prosthetic heart valve [see Warnings and Precautions (5.3)]<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher =  | date =  | accessdate = 31 January 2014 }}</ref>
-==References==
-{{Reflist|2}}
-[[Category:Direct thrombin (II) inhibitors]]
-[[Category:Anticoagulants]]
-[[Category:Cardiovascular Drugs]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}